Search - Inserm - Institut national de la santé et de la recherche médicale Access content directly

Filter your results

4 Results
authFullName_s : Carmen Loquai
Image document

Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma

Paolo Antonio Ascierto , Michelle del Vecchio , Andrzej Mackiewicz , Caroline Robert , Vanna Chiarion-Sileni , et al.
Journal for Immunotherapy of Cancer, 2020, 8 (1), pp.e000391. ⟨10.1136/jitc-2019-000391⟩
Journal articles inserm-03709901v1
Image document

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

Paolo A Ascierto , Michele Del Vecchio , Caroline Robert , Andrzej Mackiewicz , Vanna Chiarion-Sileni , et al.
Lancet Oncology, 2017, 18 (5), pp.611-622. ⟨10.1016/S1470-2045(17)30231-0⟩
Journal articles inserm-01807340v1
Image document

Sonidegib improved quality of life in patients with advanced basal cell carcinoma: results from the phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment trial through 73 weeks

Michael Migden , Carmen Loquai , Caroline Robert , Jean- François Baurain , Nicholas Squittieri , et al.
Journal of The American Academy of Dermatology, 2022, Online ahead of print. ⟨10.1016/j.jdin.2022.08.027⟩
Journal articles inserm-03818996v1
Image document

Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover

Celeste Lebbé , Caroline Dutriaux , Thierry Lesimple , Willem Kruit , Joseph Kerger , et al.
Cancers, 2020, 12 (7), pp.1727. ⟨10.3390/cancers12071727⟩
Journal articles hal-03256625v1